| | Scope | Document part | Language | Document |
|---|
| DEU AMG - Arzneimittelgesetz 19-Jul-2023 § 40a | G | § 40a | DE | DEU AMG - Arzneimittelgesetz 19-Jul-2023 |
| DEU AMG - Arzneimittelgesetz 19-Jul-2023 § 40b-001 | G | § 40b | DE | DEU AMG - Arzneimittelgesetz 19-Jul-2023 |
| DEU AMG - Arzneimittelgesetz 19-Jul-2023 § 41b | G | § 41b | DE | DEU AMG - Arzneimittelgesetz 19-Jul-2023 |
| DEU AMG - Arzneimittelgesetz 19-Jul-2023 § 42b | HM | § 42b | DE | DEU AMG - Arzneimittelgesetz 19-Jul-2023 |
| DEU AMG - Arzneimittelgesetz 19-Jul-2023 § 63 f Absatz 1 – 3 | HM | § 63 f
Absatz 1 – 3 | DE | DEU AMG - Arzneimittelgesetz 19-Jul-2023 |
| DEU AMG - Arzneimittelgesetz 19-Jul-2023 § 63 g Absatz 1 – 2 | HM | § 63 g
Absatz 1 – 2 | DE | DEU AMG - Arzneimittelgesetz 19-Jul-2023 |
| DEU AMG - Arzneimittelgesetz 19-Jul-2023 § 63f | HM | § 63f | DE | DEU AMG - Arzneimittelgesetz 19-Jul-2023 |
| DEU AMG - Arzneimittelgesetz 19-Jul-2023 § 63g | HM | § 63g | DE | DEU AMG - Arzneimittelgesetz 19-Jul-2023 |
| DEU DGEPi - GEP Guter Epidemiologischer Praxis Sep-2018 Leitlinie 4 | NIS | Leitlinie 4 | DE | DEU DGEPi - GEP Guter Epidemiologischer Praxis Sep-2018 |
| DEU DGEPi - GEP Guter Epidemiologischer Praxis Sep-2018 Leitlinie 6 6.1 | NIS | Leitlinie 6
6.1 | DE | DEU DGEPi - GEP Guter Epidemiologischer Praxis Sep-2018 |
| DEU Gemeinsame Empfehlungen - zur Anzeige von Anwendungsbeobachtungen und nichtinterventionellen Unbedenklichkeits-studien 15-Dec-2022 1.2 | NIS | 1.2 | DE | DEU Gemeinsame Empfehlungen - zur Anzeige von Anwendungsbeobachtungen und nichtinterventionellen Unbedenklichkeits-studien 15-Dec-2022 |
| DEU Gemeinsame Empfehlungen - zur Anzeige von Anwendungsbeobachtungen und nichtinterventionellen Unbedenklichkeits-studien 15-Dec-2022 3.2 | NIS | 3.2 | DE | DEU Gemeinsame Empfehlungen - zur Anzeige von Anwendungsbeobachtungen und nichtinterventionellen Unbedenklichkeits-studien 15-Dec-2022 |
| DEU KPBV - Klinische Prüfung-Bewertungsverfahren-Verordnung 31-Jan-2022 § 4 | G | § 4 | DE | DEU KPBV - Klinische Prüfung-Bewertungsverfahren-Verordnung 31-Jan-2022 |
| DEU KPBV - Klinische Prüfung-Bewertungsverfahren-Verordnung 31-Jan-2022 § 5 | G | § 5 | DE | DEU KPBV - Klinische Prüfung-Bewertungsverfahren-Verordnung 31-Jan-2022 |
| DEU MPDG - Medizinprodukterecht-Durchführungsgesetz 28-Jun-2022 § 28 Absatz 1 – 2 | MD | § 28
Absatz 1 – 2 | DE | DEU MPDG - Medizinprodukterecht-Durchführungsgesetz 28-Jun-2022 |
| DEU MPDG - Medizinprodukterecht-Durchführungsgesetz 28-Jun-2022 § 47-001 | MD | § 47 | DE | DEU MPDG - Medizinprodukterecht-Durchführungsgesetz 28-Jun-2022 |
| DEU MPDG - Medizinprodukterecht-Durchführungsgesetz 28-Jun-2022 § 47-002 | MD | § 47 | DE | DEU MPDG - Medizinprodukterecht-Durchführungsgesetz 28-Jun-2022 |
| DEU StrlSchG - Strahlenschutzgesetz 03-Jan-2022 § 32 | G | § 32 | DE | DEU StrlSchG - Strahlenschutzgesetz 03-Jan-2022 |
| EU EMA/786433/2022 Annex V – to guidance for the conduct of good clinical practice inspections – Phase I units 15-Nov-2022 2.5-002 | G | 2.5 | EN | EU EMA/786433/2022 Annex V – to guidance for the conduct of good clinical practice inspections – Phase I units 15-Nov-2022 |
| EU GVP: Module VIII EMA/813938/2011 Rev. 3 (2017) - | NIS | - | EN | EU GVP: Module VIII EMA/813938/2011 Rev. 3 (2017) |
| EU GVP: Module VIII EMA/813938/2011 Rev. 3 (2017) VIII.B.4.3 | NIS | VIII.B.4.3 | EN | EU GVP: Module VIII EMA/813938/2011 Rev. 3 (2017) |
| EU Regulation (EU) 2016/679 (GDPR) 04-May-2016 Article 6 Paragraph 1 | G | Article 6
Paragraph 1 | EN | EU Regulation (EU) 2016/679 (GDPR) 04-May-2016 |
| EU Regulation (EU) 2016/679 (GDPR) 04-May-2016 Article 9 Paragraph 1 | G | Article 9
Paragraph 1 | EN | EU Regulation (EU) 2016/679 (GDPR) 04-May-2016 |
| EU Regulation (EU) 2016/679 (GDPR) 04-May-2016 Article 9 Paragraph 2 | G | Article 9
Paragraph 2 | EN | EU Regulation (EU) 2016/679 (GDPR) 04-May-2016 |
| EU Regulation (EU) 2017/745 - Medical Device Regulation 20-Mar-2023 Article 62 Paragraph 1 | MD | Article 62
Paragraph 1 | EN | EU Regulation (EU) 2017/745 - Medical Device Regulation 20-Mar-2023 |
| EU Regulation (EU) 2017/745 - Medical Device Regulation 20-Mar-2023 Article 62 Paragraph 4 | MD | Article 62
Paragraph 4 | EN | EU Regulation (EU) 2017/745 - Medical Device Regulation 20-Mar-2023 |
| EU Regulation (EU) 2017/745 - Medical Device Regulation 20-Mar-2023 Article 63 Paragraph 1 | MD | Article 63
Paragraph 1 | EN | EU Regulation (EU) 2017/745 - Medical Device Regulation 20-Mar-2023 |
| EU Regulation (EU) 2017/745 - Medical Device Regulation 20-Mar-2023 Article 69 | MD | Article 69 | EN | EU Regulation (EU) 2017/745 - Medical Device Regulation 20-Mar-2023 |
| EU Regulation (EU) 2017/745 - Medical Device Regulation 20-Mar-2023 Article 82 | MD | Article 82 | EN | EU Regulation (EU) 2017/745 - Medical Device Regulation 20-Mar-2023 |
| EU Regulation (EU) 2017/746 - in vitro diagnostic medical devices 20-Mar-2023 Article 57 | IVD | Article 57 | EN | EU Regulation (EU) 2017/746 - in vitro diagnostic medical devices 20-Mar-2023 |
| EU Regulation (EU) 2017/746 - in vitro diagnostic medical devices 20-Mar-2023 Article 58 Paragraph 5 (j) | IVD | Article 58
Paragraph 5
(j) | EN | EU Regulation (EU) 2017/746 - in vitro diagnostic medical devices 20-Mar-2023 |
| EU Regulation (EU) 2017/746 - in vitro diagnostic medical devices 20-Mar-2023 Article 58 Paragraph 5-001 | IVD | Article 58
Paragraph 5 | EN | EU Regulation (EU) 2017/746 - in vitro diagnostic medical devices 20-Mar-2023 |
| EU Regulation (EU) 2017/746 - in vitro diagnostic medical devices 20-Mar-2023 Article 58 Paragraph 5-002 | IVD | Article 58
Paragraph 5 | EN | EU Regulation (EU) 2017/746 - in vitro diagnostic medical devices 20-Mar-2023 |
| EU Regulation (EU) 2017/746 - in vitro diagnostic medical devices 20-Mar-2023 Article 59 Paragraph 1 | IVD | Article 59
Paragraph 1 | EN | EU Regulation (EU) 2017/746 - in vitro diagnostic medical devices 20-Mar-2023 |
| EU Regulation (EU) 2017/746 - in vitro diagnostic medical devices 20-Mar-2023 Article 65 | IVD | Article 65 | EN | EU Regulation (EU) 2017/746 - in vitro diagnostic medical devices 20-Mar-2023 |
| EU Regulation (EU) 536/2014 - clinical trials 05-Dec-2022 Article 29 Paragraph 1 | HM | Article 29
Paragraph 1 | EN | EU Regulation (EU) 536/2014 - clinical trials 05-Dec-2022 |
| EU Regulation (EU) 536/2014 - clinical trials 05-Dec-2022 Article 50 | HM | Article 50 | EN | EU Regulation (EU) 536/2014 - clinical trials 05-Dec-2022 |
| EU Regulation (EU) 536/2014 - clinical trials 05-Dec-2022 Article 76 | HM | Article 76 | EN | EU Regulation (EU) 536/2014 - clinical trials 05-Dec-2022 |
| EU Regulation (EU) 536/2014 - clinical trials 05-Dec-2022 Article 9 | G | Article 9 | EN | EU Regulation (EU) 536/2014 - clinical trials 05-Dec-2022 |
| EU Regulation (EU) 536/2014 - clinical trials 27-May-2014 Preamble Preamble | HM | Preamble | EN | EU Regulation (EU) 536/2014 - clinical trials 27-May-2014 Preamble |
| FRA Code de la Santé Publique - Partie Réglementaire - 1ere partie, Livre 1er, Titre II 16-May-2025 Article R1121-3-1 | G | Article R1121-3-1 | FR | FRA Code de la Santé Publique - Partie Réglementaire - 1ere partie, Livre 1er, Titre II 16-May-2025 |
| FRA Constitution du 4 octobre 1958 10-Mar-2024 Article 34 | G | Article 34 | FR | FRA Constitution du 4 octobre 1958 10-Mar-2024 |
| FRA Constitution du 4 octobre 1958 10-Mar-2024 Article 55 | G | Article 55 | FR | FRA Constitution du 4 octobre 1958 10-Mar-2024 |
| FRA Infographie - La hiérarchie des normes 22-Mar-2024 N/A | G | N/A | FR | FRA Infographie - La hiérarchie des normes 22-Mar-2024 |
| GBR Data Protection Act 2018 06-Jun-2022 Article 2 | G | Article 2 | EN | GBR Data Protection Act 2018 06-Jun-2022 |
| GBR The Electronic Identification and Trust Services for Electronic Transactions (Amendment etc.) (EU Exit) Regulations 2019 23-Jan-2019 - | G | - | EN | GBR The Electronic Identification and Trust Services for Electronic Transactions (Amendment etc.) (EU Exit) Regulations 2019 23-Jan-2019 |
| GBR The Medicines for Human Use (Clinical Trials) Regulations 2004 01-May-2004 Article 7-10 | HM | Article 7-10 | EN | GBR The Medicines for Human Use (Clinical Trials) Regulations 2004 01-May-2004 |
| GBR The Medicines for Human Use (Clinical Trials) Regulations 2004 01-May-2004 Schedule 1 Part 2 16. | HM | Schedule 1
Part 2
16. | EN | GBR The Medicines for Human Use (Clinical Trials) Regulations 2004 01-May-2004 |
| GBR UK GDPR - United Kingdom General Data Protection Regulation 31-Dec-2020 Article 6 Paragraph 1 | G | Article 6
Paragraph 1 | EN | GBR UK GDPR - United Kingdom General Data Protection Regulation 31-Dec-2020 |
| GBR UK GDPR - United Kingdom General Data Protection Regulation 31-Dec-2020 Article 9 Paragraph 1 | G | Article 9
Paragraph 1 | EN | GBR UK GDPR - United Kingdom General Data Protection Regulation 31-Dec-2020 |
| GBR UK GDPR - United Kingdom General Data Protection Regulation 31-Dec-2020 Article 9 Paragraph 2 | G | Article 9
Paragraph 2 | EN | GBR UK GDPR - United Kingdom General Data Protection Regulation 31-Dec-2020 |
| ICH ICH E3 Guideline 1995 - | G | - | EN | ICH ICH E3 Guideline 1995 |
| ICH ICH E6 Guideline R3 (2025) Appendix A | G | Appendix A | EN | ICH ICH E6 Guideline R3 (2025) |
| ICH ICH E6 Guideline R3 (2025) III. Annex 1 1 | G | III. Annex 1
1 | EN | ICH ICH E6 Guideline R3 (2025) |
| ICH ICH E6 Guideline R3 (2025) III. Annex 1 2.8 | G | III. Annex 1
2.8 | EN | ICH ICH E6 Guideline R3 (2025) |
| INT ISPE - GPP Revision 3 (2015) II. | INS | II. | EN | INT ISPE - GPP Revision 3 (2015) |
| USA 21 CFR Part 11 09-Apr-2025 § 11.100 | G | § 11.100 | EN | USA 21 CFR Part 11 09-Apr-2025 |
| USA 21 CFR Part 11 09-Apr-2025 § 11.50 | G | § 11.50 | EN | USA 21 CFR Part 11 09-Apr-2025 |
| USA 21 CFR Part 312 09-Apr-2025 § 312.40 (b) | HM | § 312.40
(b) | EN | USA 21 CFR Part 312 09-Apr-2025 |
| USA 21 CFR Part 320 09-Apr-2025 § 320.22 | HM | § 320.22 | EN | USA 21 CFR Part 320 09-Apr-2025 |
| USA 21 CFR Part 56 09-Apr-2025 Subpart B | G | Subpart B | EN | USA 21 CFR Part 56 09-Apr-2025 |
| USA 21 CFR Part 56 09-Apr-2025 Subpart C | G | Subpart C | EN | USA 21 CFR Part 56 09-Apr-2025 |
| USA 21 CFR Part 56 09-Apr-2025 § 56.103 | G | § 56.103 | EN | USA 21 CFR Part 56 09-Apr-2025 |
| USA 21 CFR Part 56 09-Apr-2025 § 56.109 | G | § 56.109 | EN | USA 21 CFR Part 56 09-Apr-2025 |
| USA 21 CFR Part 56 09-Apr-2025 § 56.111 - §56.112 | G | § 56.111
-
§56.112 | EN | USA 21 CFR Part 56 09-Apr-2025 |
| USA 21 CFR Part 812 09-Apr-2025 Subpart B | MD | Subpart B | EN | USA 21 CFR Part 812 09-Apr-2025 |
| USA 42 CFR Part 11 09-Apr-2025 § 11.24 | G | § 11.24 | EN | USA 42 CFR Part 11 09-Apr-2025 |
| USA 42 CFR Part 11 09-Apr-2025 § 11.40 | G | § 11.40 | EN | USA 42 CFR Part 11 09-Apr-2025 |
| USA 42 CFR Part 11 09-Apr-2025 § 11.54 | G | § 11.54 | EN | USA 42 CFR Part 11 09-Apr-2025 |
| USA 42 CFR Part 11 09-Apr-2025 § 11.6 | G | § 11.6 | EN | USA 42 CFR Part 11 09-Apr-2025 |
| USA 42 CFR Part 11 09-Apr-2025 § 11.64 | G | § 11.64 | EN | USA 42 CFR Part 11 09-Apr-2025 |
| USA 42 CFR Part 11 09-Apr-2025 § 11.8 | G | § 11.8 | EN | USA 42 CFR Part 11 09-Apr-2025 |
| USA 45 CFR Part 160 09-Apr-2025 § 164.508 | G | § 164.508 | EN | USA 45 CFR Part 160 09-Apr-2025 |
| USA 45 CFR Part 160 09-Apr-2025 § 164.512 | G | § 164.512 | EN | USA 45 CFR Part 160 09-Apr-2025 |
| USA 45 CFR Part 46 09-Apr-2025 Subpart E | G | Subpart E | EN | USA 45 CFR Part 46 09-Apr-2025 |
| USA 45 CFR Part 46 09-Apr-2025 § 46.107 - § 46.112 | G | § 46.107 - § 46.112 | EN | USA 45 CFR Part 46 09-Apr-2025 |
| USA 45 CFR Part 46 09-Apr-2025 § 46.113 | G | § 46.113 | EN | USA 45 CFR Part 46 09-Apr-2025 |
| USA 45 CFR Part 46 09-Apr-2025 § 46.115 | G | § 46.115 | EN | USA 45 CFR Part 46 09-Apr-2025 |
| USA 45 CFR Part 46 09-Apr-2025 § 46.123 | G | § 46.123 | EN | USA 45 CFR Part 46 09-Apr-2025 |
| USA 45 CFR Part 46 09-Apr-2025 § 46.124 | G | § 46.124 | EN | USA 45 CFR Part 46 09-Apr-2025 |
| USA FD&C Act - Federal Food, Drug, and Cosmetic Act 30-Sep-2023 Sec 510 (k) | G | Sec 510 (k) | EN | USA FD&C Act - Federal Food, Drug, and Cosmetic Act 30-Sep-2023 |
| WHO WHO - Guidelines for GCP for trials on pharmaceutical products* 1995 Glossary - 1.5 Regulatory requirements | HM | Glossary - 1.5 Regulatory requirements | EN | WHO WHO - Guidelines for GCP for trials on pharmaceutical products* 1995 |